nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—Binding and entry of HIV virion—CCR5—multiple sclerosis	0.0494	0.0947	CbGpPWpGaD
Plerixafor—CXCR4—Binding and entry of HIV virion—CD4—multiple sclerosis	0.031	0.0595	CbGpPWpGaD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—CCR5—multiple sclerosis	0.0181	0.0348	CbGpPWpGaD
Plerixafor—CXCR4—retina—multiple sclerosis	0.0167	0.199	CbGeAlD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCL13—multiple sclerosis	0.0144	0.0276	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCR1—multiple sclerosis	0.0144	0.0276	CbGpPWpGaD
Plerixafor—CXCR4—medulla oblongata—multiple sclerosis	0.0121	0.144	CbGeAlD
Plerixafor—CXCR4—CXCR4-mediated signaling events—RGS1—multiple sclerosis	0.012	0.023	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CCR1—multiple sclerosis	0.0115	0.0221	CbGpPWpGaD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—CD4—multiple sclerosis	0.0114	0.0218	CbGpPWpGaD
Plerixafor—CXCR4—midbrain—multiple sclerosis	0.0111	0.132	CbGeAlD
Plerixafor—CXCR4—spinal cord—multiple sclerosis	0.0108	0.128	CbGeAlD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—CCL5—multiple sclerosis	0.0104	0.0199	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL3—multiple sclerosis	0.0103	0.0197	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCR3—multiple sclerosis	0.00954	0.0183	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—HLA-DRA—multiple sclerosis	0.00947	0.0182	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCR2—multiple sclerosis	0.00928	0.0178	CbGpPWpGaD
Plerixafor—CXCR4—nervous system—multiple sclerosis	0.00909	0.108	CbGeAlD
Plerixafor—CXCR4—central nervous system—multiple sclerosis	0.00875	0.104	CbGeAlD
Plerixafor—CXCR4—cerebellum—multiple sclerosis	0.00856	0.102	CbGeAlD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCL10—multiple sclerosis	0.00771	0.0148	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CXCR3—multiple sclerosis	0.00763	0.0146	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CCR2—multiple sclerosis	0.00743	0.0142	CbGpPWpGaD
Plerixafor—CXCR4—brain—multiple sclerosis	0.00695	0.0827	CbGeAlD
Plerixafor—CXCR4—CXCR4-mediated signaling events—PTPRC—multiple sclerosis	0.00671	0.0129	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL5—multiple sclerosis	0.00664	0.0127	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.0062	0.0119	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCR5—multiple sclerosis	0.00598	0.0115	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.00542	0.0104	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.00542	0.0104	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—RGS1—multiple sclerosis	0.00527	0.0101	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—MMP9—multiple sclerosis	0.00512	0.00981	CbGpPWpGaD
Plerixafor—CXCR4—S1P3 pathway—MAPK1—multiple sclerosis	0.00504	0.00966	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00493	0.00946	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CCR5—multiple sclerosis	0.00478	0.00918	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.00464	0.0089	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL2—multiple sclerosis	0.00457	0.00877	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.00457	0.00877	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR1—multiple sclerosis	0.00457	0.00877	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—multiple sclerosis	0.00454	0.00871	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00424	0.00814	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00397	0.00762	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.00386	0.00741	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—HLA-DRB1—multiple sclerosis	0.00385	0.00738	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—S1PR1—multiple sclerosis	0.00375	0.0072	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00363	0.00697	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00363	0.00697	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.00359	0.00689	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.00349	0.0067	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CD28—multiple sclerosis	0.00321	0.00616	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00303	0.00581	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—GPR65—multiple sclerosis	0.00303	0.00581	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR2—multiple sclerosis	0.00295	0.00565	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—CCR5—multiple sclerosis	0.00294	0.00564	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.00291	0.00558	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.0029	0.00557	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—TGFB1—multiple sclerosis	0.00282	0.0054	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00281	0.00539	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL13—multiple sclerosis	0.00277	0.00531	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR1—multiple sclerosis	0.00277	0.00531	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.00273	0.00524	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CNR1—multiple sclerosis	0.00272	0.00521	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—CD4—multiple sclerosis	0.00271	0.00521	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	0.00266	0.0051	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00259	0.00497	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00252	0.00484	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.0025	0.00479	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00249	0.00478	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.00245	0.0047	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00241	0.00462	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—MMP9—multiple sclerosis	0.00236	0.00453	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00234	0.00449	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.00225	0.00432	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00216	0.00415	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00212	0.00407	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCL5—multiple sclerosis	0.00211	0.00404	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—STAT3—multiple sclerosis	0.0021	0.00403	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CCR5—multiple sclerosis	0.00203	0.0039	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—HLA-A—multiple sclerosis	0.00198	0.0038	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL3—multiple sclerosis	0.00197	0.00378	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00195	0.00373	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—S1PR1—multiple sclerosis	0.00193	0.0037	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—PTGER4—multiple sclerosis	0.0019	0.00364	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR5—multiple sclerosis	0.0019	0.00364	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—CD4—multiple sclerosis	0.00185	0.00354	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCR3—multiple sclerosis	0.00183	0.00352	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—RGS1—multiple sclerosis	0.0018	0.00346	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR2—multiple sclerosis	0.00178	0.00342	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.00176	0.00338	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00176	0.00337	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00172	0.0033	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GPR65—multiple sclerosis	0.00171	0.00328	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.00168	0.00321	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CNR1—multiple sclerosis	0.00165	0.00316	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—RGS1—multiple sclerosis	0.00164	0.00314	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GPC5—multiple sclerosis	0.00158	0.00303	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00156	0.003	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR1—multiple sclerosis	0.00156	0.003	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GPR65—multiple sclerosis	0.00155	0.00298	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00151	0.0029	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LINGO1—multiple sclerosis	0.0015	0.00288	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—POMC—multiple sclerosis	0.00148	0.00285	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL10—multiple sclerosis	0.00148	0.00284	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR1—multiple sclerosis	0.00142	0.00272	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL13—multiple sclerosis	0.00142	0.00272	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TAGAP—multiple sclerosis	0.0013	0.0025	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL5—multiple sclerosis	0.00128	0.00245	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CD4—multiple sclerosis	0.00128	0.00245	CbGpPWpGaD
Plerixafor—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00121	0.00307	CcSEcCtD
Plerixafor—Haemorrhage—Dexamethasone—multiple sclerosis	0.00121	0.00306	CcSEcCtD
Plerixafor—Haemorrhage—Betamethasone—multiple sclerosis	0.00121	0.00306	CcSEcCtD
Plerixafor—Rash—Cladribine—multiple sclerosis	0.0012	0.00304	CcSEcCtD
Plerixafor—Dermatitis—Cladribine—multiple sclerosis	0.0012	0.00304	CcSEcCtD
Plerixafor—Immune system disorder—Methylprednisolone—multiple sclerosis	0.0012	0.00304	CcSEcCtD
Plerixafor—Headache—Cladribine—multiple sclerosis	0.00119	0.00302	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00118	0.00226	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00117	0.00296	CcSEcCtD
Plerixafor—Mental disorder—Methylprednisolone—multiple sclerosis	0.00116	0.00294	CcSEcCtD
Plerixafor—Erythema—Triamcinolone—multiple sclerosis	0.00116	0.00293	CcSEcCtD
Plerixafor—Erythema—Methylprednisolone—multiple sclerosis	0.00115	0.00293	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00115	0.00221	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR5—multiple sclerosis	0.00115	0.0022	CbGpPWpGaD
Plerixafor—Hypersensitivity—Azathioprine—multiple sclerosis	0.00114	0.00289	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00114	0.00289	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—S1PR1—multiple sclerosis	0.00114	0.00218	CbGpPWpGaD
Plerixafor—Malaise—Prednisolone—multiple sclerosis	0.00113	0.00288	CcSEcCtD
Plerixafor—Nausea—Cladribine—multiple sclerosis	0.00113	0.00287	CcSEcCtD
Plerixafor—Syncope—Prednisolone—multiple sclerosis	0.00113	0.00286	CcSEcCtD
Plerixafor—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00112	0.00285	CcSEcCtD
Plerixafor—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00112	0.00283	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—GPC5—multiple sclerosis	0.00111	0.00212	CbGpPWpGaD
Plerixafor—Loss of consciousness—Prednisolone—multiple sclerosis	0.00111	0.0028	CcSEcCtD
Plerixafor—Dyspepsia—Mitoxantrone—multiple sclerosis	0.0011	0.00279	CcSEcCtD
Plerixafor—Fatigue—Mitoxantrone—multiple sclerosis	0.00108	0.00273	CcSEcCtD
Plerixafor—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00107	0.00272	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00107	0.00206	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00107	0.00271	CcSEcCtD
Plerixafor—Constipation—Mitoxantrone—multiple sclerosis	0.00107	0.00271	CcSEcCtD
Plerixafor—Pain—Mitoxantrone—multiple sclerosis	0.00107	0.00271	CcSEcCtD
Plerixafor—Diarrhoea—Azathioprine—multiple sclerosis	0.00106	0.00268	CcSEcCtD
Plerixafor—Discomfort—Prednisolone—multiple sclerosis	0.00106	0.00268	CcSEcCtD
Plerixafor—Haemoglobin—Prednisone—multiple sclerosis	0.00106	0.00267	CcSEcCtD
Plerixafor—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00105	0.00266	CcSEcCtD
Plerixafor—Haemorrhage—Prednisone—multiple sclerosis	0.00105	0.00266	CcSEcCtD
Plerixafor—Erythema—Betamethasone—multiple sclerosis	0.00105	0.00266	CcSEcCtD
Plerixafor—Erythema—Dexamethasone—multiple sclerosis	0.00105	0.00266	CcSEcCtD
Plerixafor—Malaise—Triamcinolone—multiple sclerosis	0.00104	0.00264	CcSEcCtD
Plerixafor—Malaise—Methylprednisolone—multiple sclerosis	0.00104	0.00264	CcSEcCtD
Plerixafor—Syncope—Triamcinolone—multiple sclerosis	0.00104	0.00263	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00104	0.00199	CbGpPWpGaD
Plerixafor—Syncope—Methylprednisolone—multiple sclerosis	0.00104	0.00262	CcSEcCtD
Plerixafor—Connective tissue disorder—Prednisone—multiple sclerosis	0.00103	0.00262	CcSEcCtD
Plerixafor—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00103	0.00261	CcSEcCtD
Plerixafor—CXCR4—Disease—RPL5—multiple sclerosis	0.00103	0.00197	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00103	0.0026	CcSEcCtD
Plerixafor—Dizziness—Azathioprine—multiple sclerosis	0.00102	0.00259	CcSEcCtD
Plerixafor—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00102	0.00259	CcSEcCtD
Plerixafor—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00102	0.00258	CcSEcCtD
Plerixafor—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00101	0.00257	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCL3—multiple sclerosis	0.00101	0.00194	CbGpPWpGaD
Plerixafor—Shock—Prednisolone—multiple sclerosis	0.00101	0.00256	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCR2—multiple sclerosis	0.00101	0.00193	CbGpPWpGaD
Plerixafor—Urticaria—Mitoxantrone—multiple sclerosis	0.000994	0.00252	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000993	0.00252	CcSEcCtD
Plerixafor—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000989	0.00251	CcSEcCtD
Plerixafor—CXCR4—Disease—SLC11A1—multiple sclerosis	0.000985	0.00189	CbGpPWpGaD
Plerixafor—Vomiting—Azathioprine—multiple sclerosis	0.000984	0.00249	CcSEcCtD
Plerixafor—Arthralgia—Methylprednisolone—multiple sclerosis	0.000983	0.00249	CcSEcCtD
Plerixafor—Rash—Azathioprine—multiple sclerosis	0.000976	0.00247	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000976	0.00247	CcSEcCtD
Plerixafor—Dermatitis—Azathioprine—multiple sclerosis	0.000975	0.00247	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—PTGER4—multiple sclerosis	0.000974	0.00187	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000974	0.00247	CcSEcCtD
Plerixafor—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000974	0.00247	CcSEcCtD
Plerixafor—Discomfort—Triamcinolone—multiple sclerosis	0.000973	0.00247	CcSEcCtD
Plerixafor—Discomfort—Methylprednisolone—multiple sclerosis	0.000971	0.00246	CcSEcCtD
Plerixafor—Headache—Azathioprine—multiple sclerosis	0.00097	0.00246	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—RGS1—multiple sclerosis	0.000968	0.00186	CbGpPWpGaD
Plerixafor—Dry mouth—Triamcinolone—multiple sclerosis	0.000963	0.00244	CcSEcCtD
Plerixafor—Immune system disorder—Prednisone—multiple sclerosis	0.000949	0.0024	CcSEcCtD
Plerixafor—Malaise—Dexamethasone—multiple sclerosis	0.000947	0.0024	CcSEcCtD
Plerixafor—Malaise—Betamethasone—multiple sclerosis	0.000947	0.0024	CcSEcCtD
Plerixafor—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000944	0.00239	CcSEcCtD
Plerixafor—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000942	0.00239	CcSEcCtD
Plerixafor—Syncope—Dexamethasone—multiple sclerosis	0.000941	0.00239	CcSEcCtD
Plerixafor—Syncope—Betamethasone—multiple sclerosis	0.000941	0.00239	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CXCR3—multiple sclerosis	0.000941	0.0018	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CNR1—multiple sclerosis	0.00093	0.00178	CbGpPWpGaD
Plerixafor—Shock—Triamcinolone—multiple sclerosis	0.000929	0.00235	CcSEcCtD
Plerixafor—Insomnia—Prednisolone—multiple sclerosis	0.000929	0.00235	CcSEcCtD
Plerixafor—Shock—Methylprednisolone—multiple sclerosis	0.000927	0.00235	CcSEcCtD
Plerixafor—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000924	0.00234	CcSEcCtD
Plerixafor—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000923	0.00234	CcSEcCtD
Plerixafor—Loss of consciousness—Betamethasone—multiple sclerosis	0.000923	0.00234	CcSEcCtD
Plerixafor—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000922	0.00234	CcSEcCtD
Plerixafor—Paraesthesia—Prednisolone—multiple sclerosis	0.000922	0.00234	CcSEcCtD
Plerixafor—Mental disorder—Prednisone—multiple sclerosis	0.00092	0.00233	CcSEcCtD
Plerixafor—Nausea—Azathioprine—multiple sclerosis	0.00092	0.00233	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—GPR65—multiple sclerosis	0.000917	0.00176	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR2—multiple sclerosis	0.000915	0.00176	CbGpPWpGaD
Plerixafor—Skin disorder—Methylprednisolone—multiple sclerosis	0.000915	0.00232	CcSEcCtD
Plerixafor—Erythema—Prednisone—multiple sclerosis	0.000914	0.00232	CcSEcCtD
Plerixafor—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000913	0.00231	CcSEcCtD
Plerixafor—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000911	0.00231	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—POMC—multiple sclerosis	0.000898	0.00172	CbGpPWpGaD
Plerixafor—Asthenia—Mitoxantrone—multiple sclerosis	0.000898	0.00228	CcSEcCtD
Plerixafor—Discomfort—Betamethasone—multiple sclerosis	0.000883	0.00224	CcSEcCtD
Plerixafor—Discomfort—Dexamethasone—multiple sclerosis	0.000883	0.00224	CcSEcCtD
Plerixafor—Haemoglobin—Methotrexate—multiple sclerosis	0.000882	0.00224	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CCL2—multiple sclerosis	0.000879	0.00169	CbGpPWpGaD
Plerixafor—Pain—Prednisolone—multiple sclerosis	0.000878	0.00223	CcSEcCtD
Plerixafor—Haemorrhage—Methotrexate—multiple sclerosis	0.000878	0.00222	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00086	0.00218	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000858	0.00218	CcSEcCtD
Plerixafor—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000857	0.00217	CcSEcCtD
Plerixafor—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000857	0.00217	CcSEcCtD
Plerixafor—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000856	0.00217	CcSEcCtD
Plerixafor—Insomnia—Triamcinolone—multiple sclerosis	0.000854	0.00216	CcSEcCtD
Plerixafor—Insomnia—Methylprednisolone—multiple sclerosis	0.000852	0.00216	CcSEcCtD
Plerixafor—Ill-defined disorder—Prednisone—multiple sclerosis	0.000848	0.00215	CcSEcCtD
Plerixafor—Paraesthesia—Triamcinolone—multiple sclerosis	0.000848	0.00215	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisolone—multiple sclerosis	0.000846	0.00214	CcSEcCtD
Plerixafor—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000846	0.00214	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CNR1—multiple sclerosis	0.000845	0.00162	CbGpPWpGaD
Plerixafor—Shock—Betamethasone—multiple sclerosis	0.000843	0.00214	CcSEcCtD
Plerixafor—Shock—Dexamethasone—multiple sclerosis	0.000843	0.00214	CcSEcCtD
Plerixafor—Dyspnoea—Triamcinolone—multiple sclerosis	0.000842	0.00213	CcSEcCtD
Plerixafor—Nervous system disorder—Betamethasone—multiple sclerosis	0.00084	0.00213	CcSEcCtD
Plerixafor—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00084	0.00213	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCR1—multiple sclerosis	0.000839	0.00161	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL13—multiple sclerosis	0.000839	0.00161	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000838	0.00161	CbGpPWpGaD
Plerixafor—Dyspepsia—Triamcinolone—multiple sclerosis	0.000831	0.00211	CcSEcCtD
Plerixafor—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000829	0.0021	CcSEcCtD
Plerixafor—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000828	0.0021	CcSEcCtD
Plerixafor—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000828	0.0021	CcSEcCtD
Plerixafor—Malaise—Prednisone—multiple sclerosis	0.000824	0.00209	CcSEcCtD
Plerixafor—Syncope—Prednisone—multiple sclerosis	0.00082	0.00208	CcSEcCtD
Plerixafor—Urticaria—Prednisolone—multiple sclerosis	0.000816	0.00207	CcSEcCtD
Plerixafor—Fatigue—Triamcinolone—multiple sclerosis	0.000814	0.00206	CcSEcCtD
Plerixafor—Fatigue—Methylprednisolone—multiple sclerosis	0.000812	0.00206	CcSEcCtD
Plerixafor—Pain—Triamcinolone—multiple sclerosis	0.000807	0.00205	CcSEcCtD
Plerixafor—Loss of consciousness—Prednisone—multiple sclerosis	0.000804	0.00204	CcSEcCtD
Plerixafor—Vomiting—Mitoxantrone—multiple sclerosis	0.000796	0.00202	CcSEcCtD
Plerixafor—Immune system disorder—Methotrexate—multiple sclerosis	0.000793	0.00201	CcSEcCtD
Plerixafor—Rash—Mitoxantrone—multiple sclerosis	0.000789	0.002	CcSEcCtD
Plerixafor—Dermatitis—Mitoxantrone—multiple sclerosis	0.000788	0.002	CcSEcCtD
Plerixafor—CXCR4—Disease—CD28—multiple sclerosis	0.000786	0.00151	CbGpPWpGaD
Plerixafor—Headache—Mitoxantrone—multiple sclerosis	0.000784	0.00199	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000781	0.00198	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000781	0.00198	CcSEcCtD
Plerixafor—Arthralgia—Prednisone—multiple sclerosis	0.000778	0.00197	CcSEcCtD
Plerixafor—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000778	0.00197	CcSEcCtD
Plerixafor—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000776	0.00197	CcSEcCtD
Plerixafor—Insomnia—Dexamethasone—multiple sclerosis	0.000775	0.00196	CcSEcCtD
Plerixafor—Insomnia—Betamethasone—multiple sclerosis	0.000775	0.00196	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000773	0.00196	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00077	0.00195	CcSEcCtD
Plerixafor—Paraesthesia—Betamethasone—multiple sclerosis	0.000769	0.00195	CcSEcCtD
Plerixafor—Paraesthesia—Dexamethasone—multiple sclerosis	0.000769	0.00195	CcSEcCtD
Plerixafor—Discomfort—Prednisone—multiple sclerosis	0.000769	0.00195	CcSEcCtD
Plerixafor—Mental disorder—Methotrexate—multiple sclerosis	0.000769	0.00195	CcSEcCtD
Plerixafor—Erythema—Methotrexate—multiple sclerosis	0.000764	0.00194	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CXCL10—multiple sclerosis	0.000761	0.00146	CbGpPWpGaD
Plerixafor—Hypersensitivity—Prednisolone—multiple sclerosis	0.000756	0.00192	CcSEcCtD
Plerixafor—Dyspepsia—Dexamethasone—multiple sclerosis	0.000754	0.00191	CcSEcCtD
Plerixafor—Dyspepsia—Betamethasone—multiple sclerosis	0.000754	0.00191	CcSEcCtD
Plerixafor—Urticaria—Triamcinolone—multiple sclerosis	0.00075	0.0019	CcSEcCtD
Plerixafor—Urticaria—Methylprednisolone—multiple sclerosis	0.000748	0.0019	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisone—multiple sclerosis	0.000746	0.00189	CcSEcCtD
Plerixafor—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000745	0.00189	CcSEcCtD
Plerixafor—Nausea—Mitoxantrone—multiple sclerosis	0.000743	0.00188	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00074	0.00187	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00074	0.00187	CcSEcCtD
Plerixafor—Fatigue—Dexamethasone—multiple sclerosis	0.000739	0.00187	CcSEcCtD
Plerixafor—Fatigue—Betamethasone—multiple sclerosis	0.000739	0.00187	CcSEcCtD
Plerixafor—Shock—Prednisone—multiple sclerosis	0.000734	0.00186	CcSEcCtD
Plerixafor—Pain—Dexamethasone—multiple sclerosis	0.000733	0.00186	CcSEcCtD
Plerixafor—Pain—Betamethasone—multiple sclerosis	0.000733	0.00186	CcSEcCtD
Plerixafor—Nervous system disorder—Prednisone—multiple sclerosis	0.000732	0.00185	CcSEcCtD
Plerixafor—Skin disorder—Prednisone—multiple sclerosis	0.000725	0.00184	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisone—multiple sclerosis	0.000721	0.00183	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCL5—multiple sclerosis	0.000721	0.00138	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000709	0.0018	CcSEcCtD
Plerixafor—Feeling abnormal—Betamethasone—multiple sclerosis	0.000706	0.00179	CcSEcCtD
Plerixafor—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000706	0.00179	CcSEcCtD
Plerixafor—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000701	0.00178	CcSEcCtD
Plerixafor—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000701	0.00178	CcSEcCtD
Plerixafor—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000696	0.00176	CcSEcCtD
Plerixafor—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000694	0.00176	CcSEcCtD
Plerixafor—Malaise—Methotrexate—multiple sclerosis	0.000689	0.00175	CcSEcCtD
Plerixafor—Urticaria—Betamethasone—multiple sclerosis	0.000681	0.00172	CcSEcCtD
Plerixafor—Urticaria—Dexamethasone—multiple sclerosis	0.000681	0.00172	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00068	0.00172	CcSEcCtD
Plerixafor—Dizziness—Prednisolone—multiple sclerosis	0.000679	0.00172	CcSEcCtD
Plerixafor—Asthenia—Triamcinolone—multiple sclerosis	0.000677	0.00172	CcSEcCtD
Plerixafor—Abdominal pain—Dexamethasone—multiple sclerosis	0.000677	0.00172	CcSEcCtD
Plerixafor—Abdominal pain—Betamethasone—multiple sclerosis	0.000677	0.00172	CcSEcCtD
Plerixafor—Asthenia—Methylprednisolone—multiple sclerosis	0.000676	0.00171	CcSEcCtD
Plerixafor—Insomnia—Prednisone—multiple sclerosis	0.000675	0.00171	CcSEcCtD
Plerixafor—Paraesthesia—Prednisone—multiple sclerosis	0.00067	0.0017	CcSEcCtD
Plerixafor—Pruritus—Triamcinolone—multiple sclerosis	0.000668	0.00169	CcSEcCtD
Plerixafor—Pruritus—Methylprednisolone—multiple sclerosis	0.000667	0.00169	CcSEcCtD
Plerixafor—Dyspepsia—Prednisone—multiple sclerosis	0.000657	0.00166	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCL5—multiple sclerosis	0.000655	0.00126	CbGpPWpGaD
Plerixafor—Arthralgia—Methotrexate—multiple sclerosis	0.00065	0.00165	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCR5—multiple sclerosis	0.00065	0.00125	CbGpPWpGaD
Plerixafor—Rash—Prednisolone—multiple sclerosis	0.000647	0.00164	CcSEcCtD
Plerixafor—Dermatitis—Prednisolone—multiple sclerosis	0.000647	0.00164	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000646	0.00164	CcSEcCtD
Plerixafor—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000645	0.00163	CcSEcCtD
Plerixafor—Fatigue—Prednisone—multiple sclerosis	0.000643	0.00163	CcSEcCtD
Plerixafor—Headache—Prednisolone—multiple sclerosis	0.000643	0.00163	CcSEcCtD
Plerixafor—Discomfort—Methotrexate—multiple sclerosis	0.000643	0.00163	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00064	0.00123	CbGpPWpGaD
Plerixafor—Constipation—Prednisone—multiple sclerosis	0.000638	0.00162	CcSEcCtD
Plerixafor—Dizziness—Triamcinolone—multiple sclerosis	0.000624	0.00158	CcSEcCtD
Plerixafor—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000624	0.00158	CcSEcCtD
Plerixafor—Dizziness—Methylprednisolone—multiple sclerosis	0.000623	0.00158	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisone—multiple sclerosis	0.000615	0.00156	CcSEcCtD
Plerixafor—Asthenia—Betamethasone—multiple sclerosis	0.000615	0.00156	CcSEcCtD
Plerixafor—Asthenia—Dexamethasone—multiple sclerosis	0.000615	0.00156	CcSEcCtD
Plerixafor—Nervous system disorder—Methotrexate—multiple sclerosis	0.000612	0.00155	CcSEcCtD
Plerixafor—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00061	0.00155	CcSEcCtD
Plerixafor—Nausea—Prednisolone—multiple sclerosis	0.00061	0.00155	CcSEcCtD
Plerixafor—Pruritus—Betamethasone—multiple sclerosis	0.000606	0.00154	CcSEcCtD
Plerixafor—Pruritus—Dexamethasone—multiple sclerosis	0.000606	0.00154	CcSEcCtD
Plerixafor—Skin disorder—Methotrexate—multiple sclerosis	0.000606	0.00153	CcSEcCtD
Plerixafor—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000603	0.00153	CcSEcCtD
Plerixafor—Vomiting—Triamcinolone—multiple sclerosis	0.0006	0.00152	CcSEcCtD
Plerixafor—Vomiting—Methylprednisolone—multiple sclerosis	0.000599	0.00152	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCL3—multiple sclerosis	0.000598	0.00115	CbGpPWpGaD
Plerixafor—Rash—Triamcinolone—multiple sclerosis	0.000595	0.00151	CcSEcCtD
Plerixafor—Dermatitis—Triamcinolone—multiple sclerosis	0.000595	0.00151	CcSEcCtD
Plerixafor—Rash—Methylprednisolone—multiple sclerosis	0.000594	0.00151	CcSEcCtD
Plerixafor—Dermatitis—Methylprednisolone—multiple sclerosis	0.000593	0.0015	CcSEcCtD
Plerixafor—Urticaria—Prednisone—multiple sclerosis	0.000593	0.0015	CcSEcCtD
Plerixafor—Headache—Triamcinolone—multiple sclerosis	0.000592	0.0015	CcSEcCtD
Plerixafor—Headache—Methylprednisolone—multiple sclerosis	0.00059	0.0015	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCR5—multiple sclerosis	0.00059	0.00113	CbGpPWpGaD
Plerixafor—Abdominal pain—Prednisone—multiple sclerosis	0.00059	0.00149	CcSEcCtD
Plerixafor—Diarrhoea—Dexamethasone—multiple sclerosis	0.000586	0.00149	CcSEcCtD
Plerixafor—Diarrhoea—Betamethasone—multiple sclerosis	0.000586	0.00149	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—IL2RA—multiple sclerosis	0.000581	0.00112	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTGER4—multiple sclerosis	0.000576	0.0011	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000568	0.00144	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PGR—multiple sclerosis	0.000567	0.00109	CbGpPWpGaD
Plerixafor—Dizziness—Betamethasone—multiple sclerosis	0.000567	0.00144	CcSEcCtD
Plerixafor—Dizziness—Dexamethasone—multiple sclerosis	0.000567	0.00144	CcSEcCtD
Plerixafor—Insomnia—Methotrexate—multiple sclerosis	0.000564	0.00143	CcSEcCtD
Plerixafor—CXCR4—Disease—CD86—multiple sclerosis	0.000561	0.00108	CbGpPWpGaD
Plerixafor—Nausea—Triamcinolone—multiple sclerosis	0.000561	0.00142	CcSEcCtD
Plerixafor—Paraesthesia—Methotrexate—multiple sclerosis	0.00056	0.00142	CcSEcCtD
Plerixafor—Nausea—Methylprednisolone—multiple sclerosis	0.00056	0.00142	CcSEcCtD
Plerixafor—Dyspnoea—Methotrexate—multiple sclerosis	0.000556	0.00141	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CXCR3—multiple sclerosis	0.000556	0.00107	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CD28—multiple sclerosis	0.000551	0.00106	CbGpPWpGaD
Plerixafor—Hypersensitivity—Prednisone—multiple sclerosis	0.00055	0.00139	CcSEcCtD
Plerixafor—Dyspepsia—Methotrexate—multiple sclerosis	0.000549	0.00139	CcSEcCtD
Plerixafor—Vomiting—Dexamethasone—multiple sclerosis	0.000545	0.00138	CcSEcCtD
Plerixafor—Vomiting—Betamethasone—multiple sclerosis	0.000545	0.00138	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCR2—multiple sclerosis	0.000541	0.00104	CbGpPWpGaD
Plerixafor—Rash—Betamethasone—multiple sclerosis	0.00054	0.00137	CcSEcCtD
Plerixafor—Rash—Dexamethasone—multiple sclerosis	0.00054	0.00137	CcSEcCtD
Plerixafor—Dermatitis—Dexamethasone—multiple sclerosis	0.00054	0.00137	CcSEcCtD
Plerixafor—Dermatitis—Betamethasone—multiple sclerosis	0.00054	0.00137	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000538	0.00136	CcSEcCtD
Plerixafor—Fatigue—Methotrexate—multiple sclerosis	0.000538	0.00136	CcSEcCtD
Plerixafor—Headache—Dexamethasone—multiple sclerosis	0.000537	0.00136	CcSEcCtD
Plerixafor—Headache—Betamethasone—multiple sclerosis	0.000537	0.00136	CcSEcCtD
Plerixafor—Asthenia—Prednisone—multiple sclerosis	0.000535	0.00136	CcSEcCtD
Plerixafor—Pain—Methotrexate—multiple sclerosis	0.000533	0.00135	CcSEcCtD
Plerixafor—Pruritus—Prednisone—multiple sclerosis	0.000528	0.00134	CcSEcCtD
Plerixafor—Feeling abnormal—Methotrexate—multiple sclerosis	0.000514	0.0013	CcSEcCtD
Plerixafor—Diarrhoea—Prednisone—multiple sclerosis	0.000511	0.00129	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00051	0.00129	CcSEcCtD
Plerixafor—Nausea—Dexamethasone—multiple sclerosis	0.000509	0.00129	CcSEcCtD
Plerixafor—Nausea—Betamethasone—multiple sclerosis	0.000509	0.00129	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—POMC—multiple sclerosis	0.000508	0.000974	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CNR1—multiple sclerosis	0.000499	0.000957	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CCR5—multiple sclerosis	0.000498	0.000954	CbGpPWpGaD
Plerixafor—Urticaria—Methotrexate—multiple sclerosis	0.000495	0.00126	CcSEcCtD
Plerixafor—Dizziness—Prednisone—multiple sclerosis	0.000493	0.00125	CcSEcCtD
Plerixafor—Abdominal pain—Methotrexate—multiple sclerosis	0.000493	0.00125	CcSEcCtD
Plerixafor—CXCR4—Disease—HLA-A—multiple sclerosis	0.000485	0.00093	CbGpPWpGaD
Plerixafor—Vomiting—Prednisone—multiple sclerosis	0.000474	0.0012	CcSEcCtD
Plerixafor—Rash—Prednisone—multiple sclerosis	0.00047	0.00119	CcSEcCtD
Plerixafor—Dermatitis—Prednisone—multiple sclerosis	0.00047	0.00119	CcSEcCtD
Plerixafor—Headache—Prednisone—multiple sclerosis	0.000467	0.00118	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—POMC—multiple sclerosis	0.000461	0.000884	CbGpPWpGaD
Plerixafor—Hypersensitivity—Methotrexate—multiple sclerosis	0.000459	0.00116	CcSEcCtD
Plerixafor—CXCR4—Disease—APOE—multiple sclerosis	0.000453	0.000868	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL2—multiple sclerosis	0.000451	0.000865	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL10—multiple sclerosis	0.000449	0.000862	CbGpPWpGaD
Plerixafor—Asthenia—Methotrexate—multiple sclerosis	0.000447	0.00113	CcSEcCtD
Plerixafor—Nausea—Prednisone—multiple sclerosis	0.000443	0.00112	CcSEcCtD
Plerixafor—Pruritus—Methotrexate—multiple sclerosis	0.000441	0.00112	CcSEcCtD
Plerixafor—Diarrhoea—Methotrexate—multiple sclerosis	0.000427	0.00108	CcSEcCtD
Plerixafor—Dizziness—Methotrexate—multiple sclerosis	0.000412	0.00104	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—TYK2—multiple sclerosis	0.00041	0.000786	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CD80—multiple sclerosis	0.000409	0.000785	CbGpPWpGaD
Plerixafor—Vomiting—Methotrexate—multiple sclerosis	0.000396	0.001	CcSEcCtD
Plerixafor—Rash—Methotrexate—multiple sclerosis	0.000393	0.000996	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CD86—multiple sclerosis	0.000393	0.000754	CbGpPWpGaD
Plerixafor—Dermatitis—Methotrexate—multiple sclerosis	0.000393	0.000995	CcSEcCtD
Plerixafor—Headache—Methotrexate—multiple sclerosis	0.000391	0.00099	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCL5—multiple sclerosis	0.000387	0.000742	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IL2—multiple sclerosis	0.000375	0.00072	CbGpPWpGaD
Plerixafor—Nausea—Methotrexate—multiple sclerosis	0.00037	0.000939	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—SPP1—multiple sclerosis	0.000358	0.000687	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR5—multiple sclerosis	0.000348	0.000668	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TYK2—multiple sclerosis	0.000346	0.000663	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL2RA—multiple sclerosis	0.000343	0.000659	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL2—multiple sclerosis	0.000341	0.000654	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOE—multiple sclerosis	0.000317	0.000608	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CD4—multiple sclerosis	0.000312	0.000599	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CD80—multiple sclerosis	0.000287	0.00055	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—POMC—multiple sclerosis	0.000272	0.000522	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL2—multiple sclerosis	0.000266	0.000511	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—MAPK1—multiple sclerosis	0.000261	0.0005	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TYK2—multiple sclerosis	0.000242	0.000464	CbGpPWpGaD
Plerixafor—CXCR4—Disease—STAT3—multiple sclerosis	0.000242	0.000464	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MYC—multiple sclerosis	0.000225	0.000431	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TGFB1—multiple sclerosis	0.000224	0.00043	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MAPK1—multiple sclerosis	0.00022	0.000422	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL2—multiple sclerosis	0.000201	0.000386	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—multiple sclerosis	0.0002	0.000384	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP9—multiple sclerosis	0.000191	0.000365	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—STAT3—multiple sclerosis	0.000169	0.000325	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—multiple sclerosis	0.000169	0.000324	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MYC—multiple sclerosis	0.000157	0.000302	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TGFB1—multiple sclerosis	0.000157	0.000301	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MAPK1—multiple sclerosis	0.000154	0.000295	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—multiple sclerosis	0.000118	0.000227	CbGpPWpGaD
